Error: Could not add to watchlist. X

ViroPharma Inc

+ Watchlist
VPHM:US
Acquired
VPHM:US was acquired by SHP:LN
USD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
0.09
Market Cap (USD)
-
Shares Outstanding (m)
65.967
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

Profile
ViroPharma Incorporated is a biopharmaceutical company committed to the commercialization, development, and discovery of new medicines. The Company's products include a treatment for prophylaxis of hereditary angioedema as well a capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis.
ADDRESS
730 Stockton Drive
Exton, PA 19341-1171
United States
PHONE
1-610-458-7300